CP1
Click for more information
0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Cash Flow Report and Market Update 30 Sep 2020, page-8

  1. Furiousgeorge
    5,879 Posts.
    lightbulb Created with Sketch. 411
    clock Created with Sketch.
    06/11/20
    09:30
    Post #: 48680080
    The chews are nothing but a market test. Layton said himself the revenue from them was negligible.
    Last ann outlines the coming revenue stream. Cannpal have never made fluffy announcements. When they announce , it’s something significant. Patience required , that’s all.
    CP1 Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.